MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma.
about
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patientsThe MEK-Inhibitor Selumetinib Attenuates Tumor Growth and Reduces IL-6 Expression but Does Not Protect against Muscle Wasting in Lewis Lung Cancer Cachexia.Sirolimus and metformin synergistically inhibit hepatocellular carcinoma cell proliferation and improve long-term survival in patients with HCC related to hepatitis B virus induced cirrhosis after liver transplantation.Transarterial radioembolization vs chemoembolization for hepatocarcinoma patients: A systematic review and meta-analysis.Hepatocellular carcinoma treatment: a comparative review of emerging growth factor receptor antagonists.Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.In vitro three dimensional culture of hepatocellular carcinoma to measure prognosis and responsiveness to chemotherapeutic agents.Synthesis of cananodine by intramolecular epoxide opening.Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma.Determination of Structural Requirements of N-Substituted Tetrahydro-β-Carboline Imidazolium Salt Derivatives Using in Silico Approaches for Designing MEK-1 Inhibitors.
P2860
Q26799469-58AB8060-9290-4503-A298-A69CA0D83556Q37590551-2CD6EB74-3C67-4B7C-AF09-116BE5AC44B0Q37641827-7AC587B6-56F4-4A3A-ACD5-756DED96CE71Q38883028-CF4A294B-9408-4376-B8DA-2536FAE48850Q39307416-536406AD-78A4-4ADF-8F2C-B04B1375AEEDQ39815313-C04C74CF-2F89-489E-A698-B4213E36970FQ41828504-3E18B0A0-953C-4D44-B5D4-299264D824DAQ48572846-7A245880-4C0C-480E-9A50-338CC5201386Q49168467-713B45E0-B095-42D5-96B2-F43E22433973Q50936315-99C3CADE-BA8A-45BB-A13C-80DF6BE95FAA
P2860
MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma.
@en
type
label
MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma.
@en
prefLabel
MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma.
@en
P2860
P50
P1476
MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma
@en
P2093
Antonio Facciorusso
Raffaele Licinio
P2860
P304
P356
10.1586/17474124.2015.1040763
P577
2015-04-27T00:00:00Z